EnginZyme
Your partner in biomanufacturing
Solna, Sweden · Founded 2014 · $70.2M raised
- Headquarters
- Solna
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- enginzyme.com
- Total Funding
- $70.2M
- Last Round
- $22.0M Series BDec 2022
- Rounds
- 5
About
EnginZyme is a Stockholm-based industrial biotechnology company that has developed a patented enzyme immobilization technology enabling cell-free biomanufacturing — producing chemicals using enzymes rather than living organisms. Founded in 2014 at KTH Royal Institute of Technology, the platform allows industrial customers in the personal care, food, and specialty chemicals sectors to switch from energy-intensive traditional synthesis to greener, more cost-effective enzymatic processes. EnginZyme operates as a full-service technology partner, offering bespoke biocatalyst development, multi-step enzyme cascade engineering, and process integration, with validated ton-scale catalyst production. The company's approach bridges chemistry and biology, enabling industries to decarbonize manufacturing without overhauling existing infrastructure.
Summary
EnginZyme is a Biotech company based in Solna, Sweden, founded in 2014. It has raised $70.2M in total across 5 rounds, most recently a $22.0M Series B round in Dec 2022. Investors include Sofinnova Partners, Industrifonden and Bunge Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Leading North American energy infrastructure platform.
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Self-driving cars.
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Sustainable infrastructure finance